Literature DB >> 9767090

Ultrastructural characterization of cationic liposome-DNA complexes showing enhanced stability in serum and high transfection activity in vivo.

B Sternberg1, K Hong, W Zheng, D Papahadjopoulos.   

Abstract

We have investigated the morphology and transfection activity of cationic liposome-DNA complexes (CLDC) under conditions relevant to both in vivo and in vitro studies. Moreover we have attempted to establish structure-function relationships relevant for high transfection activities under both conditions. CLDC were composed of dimethyldioctadecylammonium bromide with either 1, 2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) or cholesterol (Chol) interacting either with pre-condensed DNA or with uncondensed plasmid DNA. Furthermore for steric stabilization 1% poly(ethylene glycol)-phospholipid conjugate was added to CLDC containing Chol and plasmid DNA. The in vivo studies were carried out in mice following i.v. injection, and the in vitro studies were performed on SK-BR-3 human breast cancer cells in the presence of media with serum. The morphology of the CLDC, monitored by freeze-fracture electron microscopy, was investigated after mixing with mouse serum or the medium where the cells were kept. The substitution of DOPE with Chol, and the addition of N-[omega-methoxypoly(oxyethylene)-alpha-oxycarbonyl-DSPE+ ++ are producing CLDC which are stabilized with respect to time and serum, and are relatively small (100-300 nm). These stabilized complexes show high expression of a marker gene in mouse lungs reaching expression values up to 10 ng luciferase per mg tissue protein, but relatively low expression in SK-BR-3 cells in vitro. Additionally, some of the complexes containing pre-condensed DNA look like 'map-pin' structures showing heads of the size of liposomes and short, stiff and tapering tails. The in vivo transfection activity of these preparations is highest. Similar complexes containing DOPE rather than Chol as helper lipid precipitate in the presence of serum and especially of cell medium and convert into hexagonal lipid (HII) phase. Such complexes, despite their high transfection activity in vitro, show very little transfection activity in vivo. These comparisons may help us to understand the fundamental difference between in vitro and in vivo activity of CLDC: high in vitro transfection activity seems to be associated with hexagonal lipid precipitates whereas high in vivo activity seems to be related with small, stabilized complexes, which in our case also exhibit some protrusions (map-pin structures).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767090     DOI: 10.1016/s0005-2736(98)00129-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  The effect of neutral helper lipids on the structure of cationic lipid monolayers.

Authors:  A P Dabkowska; D J Barlow; A V Hughes; R A Campbell; P J Quinn; M J Lawrence
Journal:  J R Soc Interface       Date:  2011-08-10       Impact factor: 4.118

2.  Chitosan-based hybrid nanocomplex for siRNA delivery and its application for cancer therapy.

Authors:  Min-Hyo Ki; Ji-Eon Kim; Young-Nam Lee; Sang Myoung Noh; Sung-Won An; Hyun-Jong Cho; Dae-Duk Kim
Journal:  Pharm Res       Date:  2014-05-24       Impact factor: 4.200

3.  High temperature stabilization of DNA in complexes with cationic lipids.

Authors:  Yury S Tarahovsky; Vera A Rakhmanova; Richard M Epand; Robert C MacDonald
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

4.  Physicochemical characterization and purification of cationic lipoplexes.

Authors:  Y Xu; S W Hui; P Frederik; F C Szoka
Journal:  Biophys J       Date:  1999-07       Impact factor: 4.033

5.  Impact of phospholipids on plasmid packaging and toxicity of gemini nanoparticles.

Authors:  Chilbert Dong; Ildiko Badea; Masoomeh Poorghorban; Ronald Verrall; Marianna Foldvari
Journal:  J Mater Chem B       Date:  2015-09-29       Impact factor: 6.331

6.  Preparation and characterization of chitosan and trimethyl-chitosan-modified poly-(epsilon-caprolactone) nanoparticles as DNA carriers.

Authors:  Jochen Haas; M N V Ravi Kumar; Gerrit Borchard; Udo Bakowsky; Claus-Michael Lehr
Journal:  AAPS PharmSciTech       Date:  2005-08-10       Impact factor: 3.246

7.  Emerging links between surface nanotechnology and endocytosis: impact on nonviral gene delivery.

Authors:  Andrew F Adler; Kam W Leong
Journal:  Nano Today       Date:  2010-12-01       Impact factor: 20.722

8.  Osmotically induced reversible transitions in lipid-DNA mesophases.

Authors:  Dganit Danino; Ellina Kesselman; Gadiel Saper; Horia I Petrache; Daniel Harries
Journal:  Biophys J       Date:  2009-04-08       Impact factor: 4.033

9.  High sensitivity differential scanning calorimetry study of DNA-cationic liposome complexes.

Authors:  Mark Saunders; Kevin M G Taylor; Duncan Q M Craig; Karen Palin; Hazel Robson
Journal:  Pharm Res       Date:  2007-06-06       Impact factor: 4.200

10.  Quantitative silencing of EGFP reporter gene by self-assembled siRNA lipoplexes of LinOS and cholesterol.

Authors:  Abdelkader A Metwally; Ian S Blagbrough; Judith M Mantell
Journal:  Mol Pharm       Date:  2012-10-25       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.